Author:
Preston Jennifer,Biglino Giovanni,Harbottle Victoria,Dalrymple Emma,Stalford Helen,Beresford Michael W.
Abstract
Abstract
Background
The active involvement of patients and the public in the design and delivery of health research has been increasingly encouraged, if not enforced. Knowledge of how this is realised in practice, especially where children and young people (CYP) are concerned, is limited, partly due to the low level of reporting of patient and public involvement (PPI) in general. The aim of this work was to assess how researchers funded by the National Institute for Health and Care Research (NIHR) report the involvement of CYP in the design and conduct of child health research to better understand the opportunities offered to CYP, and the realities of involvement in practice.
Methods
A participation matrix, analysis framework and accompanying tools were adapted from existing frameworks, including a child-rights informed framework, the Guidance for Reporting Involvement of Patients and the Public Checklist Short Form (GRIPP2SF), and NIHR reporting expectations. Child-focused research reports were identified from the NIHR Journals Library, including any interventional or observational study involving CYP aged 0–< 24 years. In two co-design workshops with healthcare professionals and CYP, we tested and refined the participation matrix, analysis framework and accompanying tools.
Results
Only thirty-two NIHR reports out of 169 (19%) were identified as relevant and included reporting of PPI with CYP. We identified significant variability in the way PPI with CYP was reported. Only 4/32 (12%) reports fully met NIHR (and GRIPP2SF) reporting criteria. Only 3/32 (9%) reports formally evaluated or self-reflected on PPI activities with CYP, whilst 15/32 (47%) provided minimal information about CYP involvement. The most common approach to involving CYP (23/32, 72%) was through the medium of existing groups or networks.
Conclusion
Despite the NIHR’s commitment to increase the quality, transparency, and consistency of reporting PPI, the reporting of involvement with CYP remains sub-optimal. Neglecting to report key details of involvement methods and impacts deprives the research community of knowledge to advance the field of delivering ‘meaningful’ PPI with CYP. Practical guidance on how researchers can report the processes and outputs of CYP involvement more rigorously may help child health researchers to involve them more meaningfully. This research offers practical tools informed by CYP to aid the reporting process.
Funder
Hugh Greenwood Legacy for Children's Health Research Fund: Hugh Greenwood Legacy Fellowship
Publisher
Springer Science and Business Media LLC
Subject
General Health Professions,Health (social science)
Reference68 articles.
1. Department of Health. Research Governance Framework for Health and Social Care. London: Department of Health; 2005.
2. Department of Health, Best Research for Best Health. 2006. London.
3. European Medicines Agency. Patients and consumers. 2020 [cited 2022 6th April]; Available from: https://www.ema.europa.eu/en/partners-networks/patients-consumers.
4. US Food and Drug Administration. FDA patient-focused drug development guidance series for enhancing the incorporation of the patient’s voice in medical product development and regulatory decision making. 2020. [cited 2022 6 April ]; Available from: https://www.fda.gov/drugs/development-approval-process-drugs/fda-patient-focused-drug-development-guidance-series-enhancing-incorporation-patients-voice-medical.
5. UK Research and Innovation. Shared commitment to improve public involvement in research. 2022 [cited 2022 10th May ]; Available from: https://www.ukri.org/news/shared-commitment-to-improve-public-involvement-in-research/.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献